Hillmen P, Eichhorst B, Brown JR, Lamanna N, et al. Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial. J Clin Oncol 2022 Nov 17:JCO2200510. doi: 10.1200/JCO.22.00510.
PMID: 36395435